NEW YORK, July 20 /PRNewswire/ -- Susquehanna Financial Group, LLLP (SFG), the institutional broker-dealer member of the Susquehanna International Group of Companies (SIG), announced today that Gary Nachman has joined the firm as the Senior Analyst covering the Specialty Pharmaceuticals sector. Mr. Nachman, whose coverage will include names such as Allergan, Cephalon, Forest Labs, King Pharmaceuticals, Shire Pharmaceuticals and Warner Chilcott, will be based out of SFG's New York office.
"Gary is an exciting addition to SFG's growing Healthcare research team – which consists of A.J. Rice (Healthcare Facilities and Services), Chris Rigg (Managed Care) and David Turkaly (Medical Supplies and Devices)," said Mike Towey, SFG's Director of Research. "The addition of Gary brings us to 23 senior fundamental analyst teams in six major industry sectors (Financial, Consumer, Healthcare, Energy, Industrials, and TMT). Gary's coverage of the Specialty Pharmaceuticals sector is the perfect complement to our healthcare team and will further leverage our healthcare trading efforts, led by Michael Karmiol."
"Gary is a premier analyst in the sector and we are excited to have him join our formidable Healthcare vertical. Gary's research is thoughtful and differentiated and his industry experience was very appealing to us," stated Cory Carlesimo, SFG's Head of Equities. "We think that experience is additive to the investment process for our clients and is why a significant number of the 75+ hires we have made year to date have had e